69 related articles for article (PubMed ID: 30105610)
21. What is a biobank? Differing definitions among biobank stakeholders.
Shaw DM; Elger BS; Colledge F
Clin Genet; 2014 Mar; 85(3):223-7. PubMed ID: 24001330
[TBL] [Abstract][Full Text] [Related]
22. A Minimum Data Set for Sharing Biobank Samples, Information, and Data: MIABIS.
Norlin L; Fransson MN; Eriksson M; Merino-Martinez R; Anderberg M; Kurtovic S; Litton JE
Biopreserv Biobank; 2012 Aug; 10(4):343-8. PubMed ID: 24849882
[TBL] [Abstract][Full Text] [Related]
23. A High-Quality Biobank Supports Breast Cancer Research in Harbin, China.
Zhang G; Xia B; Liu T; Zhang J; Niu M; Xu S; Bai X; You Z; Xu Q; Zhang Y; Cleveland J; Zhang D; Pang D
Biopreserv Biobank; 2016 Oct; 14(5):375-382. PubMed ID: 27082785
[TBL] [Abstract][Full Text] [Related]
24. Return of Research Results in the Saudi Biobank: An Exploratory Survey.
Alahmad G; Dierickx K
Genet Test Mol Biomarkers; 2017 Mar; 21(3):166-170. PubMed ID: 28118041
[TBL] [Abstract][Full Text] [Related]
25. Predicting intention to biobank: a national survey.
Critchley CR; Nicol D; Otlowski MF; Stranger MJ
Eur J Public Health; 2012 Feb; 22(1):139-44. PubMed ID: 20926403
[TBL] [Abstract][Full Text] [Related]
26. Biobanking 3.0: evidence based and customer focused biobanking.
Simeon-Dubach D; Watson P
Clin Biochem; 2014 Mar; 47(4-5):300-8. PubMed ID: 24406300
[TBL] [Abstract][Full Text] [Related]
27. [Internet-based biobank-registers in Hungary].
Vásárhelyi B; Bencsik P; Szmolenszky A; Molnár MJ; Gyorffy B; Kosztolányi G; Tulassay T; Falus A
Orv Hetil; 2007 May; 148(20):939-43. PubMed ID: 17509975
[TBL] [Abstract][Full Text] [Related]
28. Defining biobank.
Hewitt R; Watson P
Biopreserv Biobank; 2013 Oct; 11(5):309-15. PubMed ID: 24835262
[TBL] [Abstract][Full Text] [Related]
29. "Still Rather Hazy at Present": Citizens' and Physicians' Views on Returning Results from Biobank Research Using Broad Consent.
Barazzetti G; Cavalli S; Benaroyo L; Kaufmann A
Genet Test Mol Biomarkers; 2017 Mar; 21(3):159-165. PubMed ID: 28177781
[TBL] [Abstract][Full Text] [Related]
30. The impact of development of population-based study in the biomedical field on laws and regulations: a cross-strait experience on biobank development.
Te FC; Chunyan W; Zhiyuan S
J Int Bioethique; 2012 Jun; 23(2):143-63, 181-3. PubMed ID: 22924199
[TBL] [Abstract][Full Text] [Related]
31. The Biomaterialbank of the German Competence Network of Heart Failure (CNHF) is a valuable resource for biomedical and genetic research.
Posch MG; Gelbrich G; Pieske B; Lehmkuhl E; Angermann CE; Störk S; Neumann T; Düngen HD; Scheffold T; Müller-Tasch T; Maisch B; Rauchhaus M; Dietz R; Ozcelik C;
Int J Cardiol; 2009 Jul; 136(1):108-11. PubMed ID: 18614244
[TBL] [Abstract][Full Text] [Related]
32. [Strategies for biobank networks. Classification of different approaches for locating samples and an outlook on the future within the BBMRI-ERIC].
Lablans M; Kadioglu D; Mate S; Leb I; Prokosch HU; Ückert F
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2016 Mar; 59(3):373-8. PubMed ID: 26753865
[TBL] [Abstract][Full Text] [Related]
33. The biobanking research infrastructure BBMRI_CZ: a critical tool to enhance translational cancer research.
Holub P; Greplova K; Knoflickova D; Nenutil R; Valik D
Klin Onkol; 2012; 25 Suppl 2():2S78-81. PubMed ID: 23581021
[TBL] [Abstract][Full Text] [Related]
34. An Australian Biobank Certification Scheme: A Study of Economic Costs to Participating Biobanks.
Ling R; Rush A; Carter C; Carpenter J; Watson PH; Byrne JA; Searles A
Biopreserv Biobank; 2018 Feb; 16(1):53-58. PubMed ID: 29215912
[TBL] [Abstract][Full Text] [Related]
35. Challenges and Driving Forces for Business Plans in Biobanking.
Macheiner T; Huppertz B; Bayer M; Sargsyan K
Biopreserv Biobank; 2017 Apr; 15(2):121-125. PubMed ID: 28338345
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of infrastructure, equipment and training of 28 burn units/burn centers in Germany, Austria and Switzerland.
Vogt PM; Busche MN
Burns; 2011 Mar; 37(2):257-64. PubMed ID: 21087826
[TBL] [Abstract][Full Text] [Related]
37. Impact of implementing ISO 9001:2008 standard on the Spanish Renal Research Network biobank sample transfer process.
Cortés MA; Irrazábal E; García-Jerez A; Bohórquez-Magro L; Luengo A; Ortiz-Arduán A; Calleros L; Rodríguez-Puyol M
Nefrologia; 2014; 34(5):552-60. PubMed ID: 25036260
[TBL] [Abstract][Full Text] [Related]
38. Cost-effective organization of an institutional human cancer biobank in a clinical setting: CRO-Biobank experience toward harmonization.
Cervo S; De Paoli P; Perin T; Canzonieri V; Steffan A
Int J Biol Markers; 2015 May; 30(2):e243-51. PubMed ID: 25744364
[TBL] [Abstract][Full Text] [Related]
39. International requirements for consent in biobank research: qualitative review of research guidelines.
Hirschberg I; Kahrass H; Strech D
J Med Genet; 2014 Dec; 51(12):773-81. PubMed ID: 25351952
[TBL] [Abstract][Full Text] [Related]
40. Should donors be allowed to give broad consent to future biobank research?
Hansson MG; Dillner J; Bartram CR; Carlson JA; Helgesson G
Lancet Oncol; 2006 Mar; 7(3):266-9. PubMed ID: 16510336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
